Tenley Archer - Related publications

2020- Algen Biotechnologies 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Bhat S, Kabekkodu SP, Adiga D, Fernandes R, Shukla V, Bhandari P, Pandey D, Sharan K, Satyamoorthy K. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer. Cell Biology and Toxicology. PMID 33566221 DOI: 10.1007/s10565-021-09582-4   
2021 Bai X, Li Y, Zeng X, Zhao Q, Zhang Z. Single-cell sequencing technology in tumor research. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 33766554 DOI: 10.1016/j.cca.2021.03.013   
2021 Yan L, Gaddis S, Coletta LD, Repass J, Powell KL, Simper MS, Chen Y, Byrom M, Zhong Y, Lin K, Liu B, Lu Y, Shen J, MacLeod MC. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer. International Journal of Molecular Sciences. 22. PMID 33652981 DOI: 10.3390/ijms22052353   
2021 Xing H, Wang P, Liu S, Jing S, Lin J, Yang J, Zhu Y, Yu M. A global integrated analysis of UNC5C down-regulation in cancers: insights from mechanism and combined treatment strategy. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 138: 111355. PMID 33706130 DOI: 10.1016/j.biopha.2021.111355   
2021 Rossi FA, Enriqué Steinberg JH, Calvo Roitberg EH, Joshi MU, Pandey A, Abba MC, Dufrusine B, Buglioni S, De Laurenzi V, Sala G, Lattanzio R, Espinosa JM, Rossi M. USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer. Oncogenesis. 10: 28. PMID 33714979 DOI: 10.1038/s41389-021-00318-x   
2021 Pan Y, Abdureyim M, Yao Q, Li X. Analysis of Differentially Expressed Genes in Endothelial Cells Following Tumor Cell Adhesion, and the Role of PRKAA2 and miR-124-3p. Frontiers in Cell and Developmental Biology. 9: 604038. PMID 33681194 DOI: 10.3389/fcell.2021.604038   
2021 Funato K, Smith RC, Saito Y, Tabar V. Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma. Cell Stem Cell. PMID 33631117 DOI: 10.1016/j.stem.2021.02.003   
2021 Li D, Peng W, Wu B, Liu H, Zhang R, Zhou R, Yao L, Ye L. Metallothionein Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the Axis. Molecules and Cells. PMID 33820882 DOI: 10.14348/molcells.2021.2179   
2021 Vélez-Reyes GL, Koes N, Ryu JH, Kaufmann G, Berner M, Weg MT, Wolf NK, Rathe SK, Ratner N, Moriarity BS, Largaespada DA. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Cancers. 13. PMID 33808166 DOI: 10.3390/cancers13071584   
2021 Lv C, Li Y, Zhang Q, Chen Y, Wei D, Wang T, Zhou B. Low Expression Indicates a Biomarker of Poor Prognosis in Patients with Renal Cell Carcinoma. Biomed Research International. 2021: 6682758. PMID 33834072 DOI: 10.1155/2021/6682758   
2021 Wang Z, Chen S, Wang G, Li S, Qin X. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma. Biomed Research International. 2021: 6622437. PMID 33604380 DOI: 10.1155/2021/6622437   
2021 Zhang C, Liu J, Wang J, Zhang T, Xu D, Hu W, Feng Z. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Frontiers in Cell and Developmental Biology. 9: 648808. PMID 33681231 DOI: 10.3389/fcell.2021.648808   
2021 Talukdar FR, Soares Lima SC, Khoueiry R, Laskar RS, Cuenin C, Sorroche BP, Boisson AC, Abedi-Ardekani B, Carreira C, Menya D, Dzamalala CP, Assefa M, Aseffa A, Miranda-Gonçalves V, Jerónimo C, et al. Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers. Cancer Research. PMID 33741694 DOI: 10.1158/0008-5472.CAN-20-3445   
2021 Kim A, Lim SM, Kim JH, Seo JS. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma. Frontiers in Immunology. 12: 598671. PMID 33717076 DOI: 10.3389/fimmu.2021.598671   
2021 Cai H, Chew SK, Li C, Tsai MK, Andrejka L, Murray CW, Hughes NW, Shuldiner EG, Ashkin EL, Tang R, Hung KL, Chen LC, Lee SYC, Yousefi M, Lin WY, et al. A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer. Cancer Discovery. PMID 33608386 DOI: 10.1158/2159-8290.CD-20-1325   
2021 Jiang SS, Ke SJ, Ke ZL, Li J, Li X, Xie XW. Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 8: 657161. PMID 33778011 DOI: 10.3389/fmolb.2021.657161   
2021 Zhang H, Song J, Dong J, Liu Z, Lin L, Wang B, Ma Q, Ma L. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer. Frontiers in Genetics. 12: 551605. PMID 33732281 DOI: 10.3389/fgene.2021.551605   
2021 Dahlmann M, Stein US. A Bioinformatic Pipeline to Identify Biomarkers for Metastasis Formation from RNA Sequencing Data. Methods in Molecular Biology (Clifton, N.J.). 2294: 221-238. PMID 33742405 DOI: 10.1007/978-1-0716-1350-4_16   
2021 Sarver AL, Xie C, Riddle MJ, Forster CL, Wang X, Lu H, Wagner W, Tolar J, Hallstrom TC. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 33658609 DOI: 10.1038/s41374-021-00573-x   
2021 Danish D, Subbarao N, Khan M, Alouffi S, Khan S. New framework for the discovery of PRC2 inhibitors: Epigenetic Drugs. Current Drug Targets. PMID 33588726 DOI: 10.2174/1389450122666210215111744   
2021 Deng K, Yao J, Huang J, Ding Y, Zuo J. Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy. Translational Oncology. 14: 101077. PMID 33774500 DOI: 10.1016/j.tranon.2021.101077   
2021 Jeon T, Ko MJ, Seo YR, Jung SJ, Seo D, Park SY, Park KU, Kim KS, Kim M, Seo JH, Park IC, Kim MJ, Bae JH, Song DK, Cho CH, et al. Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling. Cancers. 13. PMID 33801424 DOI: 10.3390/cancers13051055   
2021 Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Frontiers in Cell and Developmental Biology. 9: 642352. PMID 33681228 DOI: 10.3389/fcell.2021.642352   
2021 Li WJ, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, Tang DG. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Frontiers in Cell and Developmental Biology. 9: 640587. PMID 33763422 DOI: 10.3389/fcell.2021.640587   
2021 García-Galindo G, Castro J, Matés J, Bravo M, Ribó M, Vilanova M, Benito A. The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27. Molecules (Basel, Switzerland). 26. PMID 33801209 DOI: 10.3390/molecules26051319   
2021 Zhang Y, Xie X, Yeganeh PN, Lee DJ, Valle-Garcia D, Meza-Sosa KF, Junqueira C, Su J, Luo HR, Hide W, Lieberman J. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33627408 DOI: 10.1073/pnas.2022830118   
2021 Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Seminars in Cancer Biology. PMID 33785447 DOI: 10.1016/j.semcancer.2021.03.010   
2021 Chen Z, Wei X, Wang X, Zheng X, Chang B, Shen L, Zhu H, Yang M, Li S, Zheng X. NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib. Cell Death & Disease. 12: 377. PMID 33828084 DOI: 10.1038/s41419-021-03646-3   
2021 Pan S, Su Y, Sun B, Hao R, Gao X, Han B. Knockout of CD147 inhibits the proliferation, invasion, and drug resistance of human oral cancer CAL27 cells in Vitro and in Vivo. International Journal of Biological Macromolecules. PMID 33766595 DOI: 10.1016/j.ijbiomac.2021.03.102   
2021 Arora L, Pal D. Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression. Frontiers in Oncology. 11: 596798. PMID 33763348 DOI: 10.3389/fonc.2021.596798   
2021 Andreou T, Williams J, Brownlie RJ, Salmond RJ, Watson E, Shaw G, Melcher A, Wurdak H, Short SC, Lorger M. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. Journal For Immunotherapy of Cancer. 9. PMID 33707311 DOI: 10.1136/jitc-2020-001143   
2021 Oshimori N, Guo Y, Taniguchi S. An emerging role for cellular crosstalk in the cancer stem cell niche microenvironment. The Journal of Pathology. PMID 33634866 DOI: 10.1002/path.5655   
2021 Sano T, Sun X, Feng Y, Liu S, Hase M, Fan Y, Zha R, Wu D, Aryal UK, Li BY, Sudo A, Yokota H. Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium. Cancers. 13. PMID 33802279 DOI: 10.3390/cancers13051061   
2021 Oshi M, Tokumaru Y, Mukhopadhyay S, Yan L, Matsuyama R, Endo I, Takabe K. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer. Cells. 10. PMID 33804148 DOI: 10.3390/cells10030653   
2021 Seed RI, Kobayashi K, Ito S, Takasaka N, Cormier A, Jespersen JM, Publicover J, Trilok S, Combes AJ, Chew NW, Chapman J, Krummel MF, Lou J, Marks J, Cheng Y, et al. A tumor-specific mechanism of T enrichment mediated by the integrin αvβ8. Science Immunology. 6. PMID 33771888 DOI: 10.1126/sciimmunol.abf0558   
2021 Jessen E, Liu Y, Davila J, Kocher JP, Wang C. Determining mutational burden and signature using RNA-seq from tumor-only samples. Bmc Medical Genomics. 14: 65. PMID 33648520 DOI: 10.1186/s12920-021-00898-y   
2021 Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 142: 155479. PMID 33677228 DOI: 10.1016/j.cyto.2021.155479   
2021 Haebe SE, Shree T, Sathe A, Day G, Czerwinski DK, Grimes S, Lee H, Binkley MS, Long SR, Martin BA, Ji HP, Levy R. Single Cell Analysis Can Define Distinct Evolution of Tumor Sites in Follicular Lymphoma. Blood. PMID 33728464 DOI: 10.1182/blood.2020009855   
2021 Mokgautsi N, Wen YT, Lawal B, Khedkar H, Sumitra MR, Wu ATH, Huang HS. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential /// Suppressor with Anti-Glioblastoma Properties. International Journal of Molecular Sciences. 22. PMID 33671112 DOI: 10.3390/ijms22052464   
2021 Li M, Deng Y, Zhang W. Molecular determinants of medulloblastoma metastasis and leptomeningeal dissemination. Molecular Cancer Research : McR. PMID 33608450 DOI: 10.1158/1541-7786.MCR-20-1026   
2021 Tan J, Zhu H, Tang G, Liu H, Wanggou S, Cao Y, Xin Z, Zhou Q, Zhan C, Wu Z, Guo Y, Jiang Z, Zhao M, Ren C, Jiang X, et al. Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients. Frontiers in Genetics. 12: 616507. PMID 33732284 DOI: 10.3389/fgene.2021.616507   
2021 Benmelouka AY, Munir M, Sayed A, Attia MS, Ali MM, Negida A, Alghamdi BS, Kamal MA, Barreto GE, Ashraf GM, Meshref M, Bahbah EI. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges. International Journal of Molecular Sciences. 22. PMID 33668356 DOI: 10.3390/ijms22052258   
2021 Zhou X, Peng M, He Y, Peng J, Zhang X, Wang C, Xia X, Song W. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment. Frontiers in Oncology. 11: 619003. PMID 33767987 DOI: 10.3389/fonc.2021.619003   
2021 Zhang K, Xu C, Liu S, Jiang Y, Zhao X, Ma S, Li Y, Yang F, Wang Y, Meng P, Shi C, Han D, Wen W, Qin W. The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma. Frontiers in Oncology. 11: 644612. PMID 33791227 DOI: 10.3389/fonc.2021.644612   
2021 Miyoshi N, Haraguchi N, Mizushima T, Ishii H, Yamamoto H, Mori M. Targeting cancer stem cells in refractory cancer. Regenerative Therapy. 17: 13-19. PMID 33598510 DOI: 10.1016/j.reth.2021.01.002   
2021 Xing Y, Chen L, Gu H, Yang C, Zhao J, Chen Z, Xiong M, Kazobinka G, Liu Y, Hou T. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation. Oncogene. PMID 33619322 DOI: 10.1038/s41388-021-01693-w   
2021 Lucca LE, Axisa PP, Lu B, Harnett B, Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells. The Journal of Experimental Medicine. 218. PMID 33651881 DOI: 10.1084/jem.20200921   
2021 Prieto-García E, Díaz-García CV, Agudo-López A, Pardo-Marqués V, García-Consuegra I, Asensio-Peña S, Alonso-Riaño M, Pérez C, Gómez C, Adeva J, Paz-Ares L, López-Martín JA, Agulló-Ortuño MT. Tumor-Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread. Biomedicines. 9. PMID 33807441 DOI: 10.3390/biomedicines9040364   
2021 Kemp SB, Steele NG, Carpenter ES, Donahue KL, Bushnell GG, Morris AH, The S, Orbach SM, Sirihorachai VR, Nwosu ZC, Espinoza C, Lima F, Brown K, Girgis AA, Gunchick V, et al. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Life Science Alliance. 4. PMID 33782087 DOI: 10.26508/lsa.202000935   
2021 Klein D, Goldberg S, Theile CS, Dambra R, Haskell K, Kuhar E, Lin T, Parmar R, Manoharan M, Richter M, Wu M, Zarazowski JM, Jadhav V, Maier MA, Sepp-Lorenzino L, et al. Centyrin Ligands for Extrahepatic Delivery of siRNA. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33601052 DOI: 10.1016/j.ymthe.2021.02.015